Hepatic encephalopathy: confusion, ammonia tests and liver-related brain dysfunction

Hepatic encephalopathy (HE), also called portosystemic encephalopathy, is brain dysfunction related to liver insufficiency or blood bypassing the liver. It can affect thinking, behaviour, movement or consciousness. New confusion in someone with cirrhosis needs emergency assessment; do not assume that a previous HE episode explains every new change. Confidence is high in this clinical distinction; diagnosis, severity and treatment require assessment of the person and other possible causes.

Evidence summary

Clinical guidance, human outcome research and funding independence answer different questions. The guidance below explains care; it does not independently reproduce the trials behind a medicine or supplement.

What hepatic encephalopathy means

Cleveland Clinic describes changes in memory, concentration, personality, sleep, coordination and consciousness. They may appear gradually or in episodes. Selected symptom context. A symptom list cannot establish that liver disease caused an individual change.

EASL distinguishes acute-failure, shunt-related and cirrhosis-associated HE, and covert from overt presentations. Selected classification. Covert describes problems requiring appropriate specialist testing; it is not a diagnosis from an online reaction-time game.

Ask which clinical situation the team is assessing and what evidence supports it. A relative can explain how behaviour differs from the person’s usual state. Describe the actual change rather than trying to assign a severity grade at home; uncertainty about the label should not delay urgent care.

Liver function, bypassing blood flow and possible triggers

The liver normally processes substances carried from the digestive tract. A portosystemic shunt lets some blood bypass it. CUH’s TIPSS information explains why this can be associated with confusion after the procedure. Selected shunt mechanism. This does not mean that everyone with a shunt develops HE.

Cleveland Clinic lists infection, digestive bleeding, constipation, dehydration, kidney problems and electrolyte disturbance among possible triggers. Selected precipitating factors. Report symptoms or medicine changes without deciding that one item is the cause.

A trigger and the underlying liver or blood-flow problem may both need attention. Ask whether a new illness has been identified, what remains uncertain and which team is treating it. Calling an episode “HE” should not hide a potentially treatable infection, bleeding problem or other new medical event.

Clinical assessment, ammonia and other causes of confusion

EASL calls for investigation of alternative or additional causes of altered mental function. Ammonia alone is insufficient: a normal result raises diagnostic doubt, and routine treatment adjustment from serial ammonia measurements is not established. Selected differential and test limits.

The provider describes examination and selected blood, blood-flow or brain investigations. Selected diagnostic context. Which tests are appropriate depends on the clinical question; this article does not turn a list into a universal testing protocol.

Tell the team when the change began, whether the person is usually able to manage daily tasks, and whether there have been recent falls, illness or treatment changes. Ask what a test will resolve. A blood result and the person’s ability to communicate or stay awake are different information; neither should be interpreted in isolation.

Nutrition, protein and supplement claims

CUH’s May2025 liver-diet education emphasizes adequate protein and avoiding muscle loss. Selected nutrition principle. Ask for a dietitian’s plan for the actual liver disease, food intake and other illnesses rather than starting a restrictive “ammonia diet.”

EASL’s2022 guidance does not recommend routine zinc treatment for HE. Selected supplement limitation. Treating an identified nutritional deficiency and proving that a supplement treats HE are separate questions; no general zinc, amino-acid or probiotic regimen is supplied here.

NCCIH warns that supplements can interact with medicines and that some products can injure the liver. Include teas, extracts and powders in the medicine review. Selected safety context. No independently cleared liver cleanse or microbiome product is established here as a substitute for assessment and prescribed care.

Acute care, recurrence prevention and treatment goals

The September2026 NHS medicine original identifies lactulose use for HE. Current medicine role. Its general constipation advice should not be converted into an HE dose, waiting period or instruction to treat sudden confusion at home.

EASL’s2022 framework includes lactulose and selected adjunctive rifaximin for recurrence prevention. Attributed treatment roles. These are clinical-context recommendations; this guide has not financially cleared all underlying drug trials or independently estimated comparative benefit.

Ask whether a treatment is intended for the present episode, prevention after recovery, a precipitating illness or the underlying liver condition. If the plan contains several medicines, request an explanation of each purpose. Feeling clearer does not by itself answer whether prevention should continue or whether the original trigger has been treated.

CUH distinguishes treating cirrhosis’s cause from managing its complications and considering transplantation when appropriate. Selected wider-care context. An HE medicine is not a statement that all liver disease or transplant questions have been resolved.

Emergency warning signs and medicine harms

The national NHS advises emergency assessment for sudden confusion or slurred speech in a person with cirrhosis, and for vomiting blood or black stools. Do not drive yourself for emergency care. Current emergency warnings. Use the local emergency number; do not wait for an ammonia test or routine appointment.

Marked drowsiness, inability to wake normally or loss of consciousness requires emergency help. Stay with the person if safe and tell responders about known liver disease and the medicines used. Do not attempt to give oral treatment to someone who cannot safely swallow. Selected consciousness warning context.

The NHS lactulose source describes diarrhoea, bloating and nausea, and potassium problems with excessive diarrhoea. Selected medicine harms. Report persistent diarrhoea, weakness or other concerning change to the treating team; no self-directed dose adjustment or universal fluid volume is given here.

Medicine review and interaction questions

The NHS lactulose original asks for medicine and supplement checks and highlights diabetes assessment when used for HE. Selected suitability and interaction context. Ask how the actual prescription fits the other conditions being treated.

Bring an accurate list of prescription and nonprescription products, including medicines taken only occasionally. Explain any recent additions, missed treatment or difficulty taking the prescribed plan. Ask the clinician or pharmacist to reconcile conflicting instructions; copying another patient’s bowel-treatment schedule can obscure the purpose of your own prescription.

A change in alertness should not automatically be assigned to HE or to one suspected medicine. Ask which treatments have been reviewed as possible contributors and which remain necessary. This guide does not supply a sedative, diuretic, antibiotic or diabetes-medicine stop rule.

Who needs additional assessment and support

Confusion after a TIPSS procedure is a specific issue to report to the liver and interventional team. CUH notes that severe problems may prompt reassessment of the shunt. Selected shunt follow-up context. No blanket rule to remove, narrow or leave a shunt is provided.

Adult recurrence recommendations should not be transferred to children or to acute liver failure without specialist assessment. Pregnancy, other neurological illness and difficulty swallowing or taking medicines also deserve individual discussion. Explain the practical problem rather than assuming a standard outpatient plan applies.

Ask whether the person can currently manage medicines, transport, cooking and appointments safely. If carers are unavailable or overwhelmed, tell the team before discharge. Support needs are part of planning care, and a family member’s observations should be heard without treating them as a substitute for medical assessment.

Written plans, driving and life after an episode

Cleveland Clinic describes involving carers in appointments and daily support. Selected practical-support context. Ask what tasks need temporary help and who can provide it; the goal is a plan that can actually be followed.

EASL discusses driving assessment in HE. Selected activity-safety context. Obtain advice about driving, machinery and safety-sensitive work from the treating service and the relevant local licensing rules; a brief improvement or normal laboratory result is not automatic clearance.

Request a written account of the diagnosis, identified trigger, medicine purposes, review arrangements and emergency warning signs. Ask who will explain pending results and how to obtain advice if the prescribed plan is difficult to follow. A carer can help keep the account consistent across the liver service, primary care and pharmacy.

Experimental microbiome approaches and laboratory research

Research may investigate gut organisms, ammonia handling or other brain-related pathways. A biomarker change or a laboratory mechanism cannot establish improved cognition, fewer admissions or safe long-term treatment in people. Those are different outcomes requiring appropriate human comparisons.

No animal or in-vitro finding, seller-supported consensus or product marketing is adopted here as independent efficacy evidence. If an investigational therapy is offered, ask about its purpose, alternatives, meaningful outcomes, harms and the investigators’ and sponsor’s financial interests. Participation should have its own consent discussion.

Funding and source roles

The EASL original is used as a dated clinical framework, with incomplete separate author forms and trial chains. The complete indexed publisher2023 correction addresses a copy/paste error in Table1’s level3 evidence criteria; direct fetch remains blocked. No numerical evidence grading or technical protocol is adopted. A separately read2016 sponsored paper establishes dated author financial context only, not payment for the2022 guideline.

Provider accounts and national website funding were checked separately. Institutional public finance, medical review and nonprofit status do not certify every contributor or supporting trial. Sponsored efficacy claims remain excluded from the independent verdict; method quality and financial interests are distinct assessments.

Frequently asked questions

Does a high ammonia result prove HE? Ask the team how it fits the examination and other possible causes; no home diagnostic threshold is supplied.

Can HE occur after a liver shunt? It is a recognized potential problem to discuss with the specialist team. Shunt context.

Should I wait to see if lactulose clears new confusion? Sudden confusion in someone with cirrhosis needs emergency assessment. Emergency advice.

Should I stop eating protein? Seek a liver dietitian’s plan; adequate nutrition and muscle preservation matter. Nutrition context.

Does feeling better mean prevention treatment can stop? Ask the prescriber to review its purpose and follow-up; no home stopping rule is provided.

Sources and funding notes

Actual18p2022 EASL original selected framework read; full separate author forms remain unclosed. Complete indexed publisher2023 correction body read: Table1 level3 criteria copy/paste error corrected; direct DOI/Elsevier fetch blocked. No numerical grading, technical protocol or classification/drug-role amendment adopted. Actual7p2016 Norgine-funded consensus declarations read, Tier4/D financial only; no clinical claim and no2022 payment inferred. Actual CCDecember2023 selected original; irreversible/fatal prognostic generalizations, dated alternative/supplement benefit menus and wait-list shortcuts excluded. Actual CUHJune2024 cirrhosis, May2025 protein and January2025 TIPSS selected bodies; named nutrition brands, fixed targets, rates and shunt protocol excluded. Actual NHSFebruary2025 cirrhosis and consolidated September8,2026 lactulose; old subpages redirect, no rarity reassurance, dose, fluid volume, constipation waiting period or personal pause. Current CC/CUH accounts, EASL industry acknowledgement, national NHS and dated NCCIH finance read separately; full contributor/trial/page financial chains unclosed.

1. Original EASL hepatic encephalopathy guideline2022, full18p society mirror — Selected dated classification/differential/test/clinical roles; no technical regimen or efficacy estimate
2. Original2023 HE correction, complete indexed publisher body; direct access blocked — Indexed publisher body identifies grading-table correction; direct access blocked, no numerical grading adopted
3. Cleveland Clinic hepatic encephalopathy, December19,2023; selected context — Selected December2023 symptoms/trigger/assessment and practical context; prognosis and broad treatment claims excluded
4. Cambridge University Hospitals TIPSS education, January14,2025 — Selected January2025 shunt mechanism/reassessment; no rate or universal intervention rule
5. Cambridge University Hospitals protein/liver-disease education, May28,2025 — Selected May2025 adequate protein/muscle principle; no branded product or personal target
6. Cambridge University Hospitals cirrhosis education, June20,2024 — Selected June2024 cause/complication-care distinction only
7. National NHS cirrhosis, February10,2025; selected emergency context — Selected February2025 emergency warning context
8. National NHS lactulose, September8,2026; selected safety/context only — Actual September2026 selected role/safety/suitability; no constipation-to-HE protocol transfer
9. NCCIH supplement safety, January2019; selected safety context only — Dated supplement safety only
10. EASL own unrestricted industry-grant route and Geneva contact — Actual society grant/contact route; full ledger access gap
11. Original2016 Norgine-funded Shawcross consensus, author declarations only — Actual2016 sponsored original declarations only; no clinical or efficacy claim used
12. Cleveland Clinic own2025/2024 audited accounts, March9,2026 — Actual current75p selected provider financial routes
13. Cleveland Clinic own advertising policy, January2020 — Separate advertising/editorial boundary, dated policy
14. Cleveland Clinic own medical editorial policy — Separate own medical editorial-governance statement
15. Cambridge University Hospitals own2025–2026 audited accounts — Actual current197p selected provider finance, not exact leaflet payment
16. NHS England own 2025–2026 audited accounts — Separate current national institutional funding
17. National NHS website content and funding policy, 2022 — Separate national website policy, not provider finance
18. NCCIH actual appropriation history, through FY2024 — Historical appropriation route only
19. NCCIH separate conditional/unconditional Gift Fund authority — Separate permitted Gift Fund authority

Educational information reviewed 4 October 2026. This guide supports an informed clinical discussion; it does not diagnose an individual or provide a personal treatment regimen.